Back to Awarded Treatment Trials
Awarded Trial: 19T-002
Grant ID
19T-002
Illness
Schizophrenia
Primary Drug/Intervention
Acetazolamide
Primary Dosage
2G/day in divided doses
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Enrolling
Investigator
Vish Nimgaonkar
Sample Size
60
Duration of Study Period for Each Subject
24 weeks
Outcome Measurements
Clinical severity (PANSS 85), cognition (Trail Making Test), overall/social function (Sheehan's disability scale, Global Assessment of Function, Quality of Life Scale) and SE will be assessed.
Results
N/A
Publication
N/A
Link
N/A
PI Name
Vish Nimgaonkar
Degree
MD, PhD
Center
N/A
Institution
University of Pittsburgh
Address
3811 O'Hare Street, WPH #441
City or Town
Pittsburgh
State or Province
PA
Zip or Postal Code
15217
Country
USA
Email Address
nimga@pitt.edu